retatrutide illegal Demand for Unapproved Weight-Loss Drug Surges on Social Media Eli Lilly Preparing Retatrutide Applications

GH Secretagogue Comparison Compound Class Receptor FDA Status Ipamorelin GHRP (ghrelin mimetic) GHS-R1a Not approved CJC-1295 GHRH analog GHRH-R Not approved Sermorelin GHRH analog GHRH-R Previously approved (Geref, discontinued) Tesamorelin GHRH analog GHRH-R FDA approved (Egrifta) GHRP-2 GHRP (ghrelin mimetic) GHS-R1a Not approved GHRP-6 GHRP (ghrelin mimetic) GHS-R1a Not approved Selectivity Profile: The Key Research Differentiator What makes Ipamorelin stand out among GHRPs is its endocrine selectivity

A 10mg vial reconstituted with 2mL bacteriostatic water yields a 5mg/mL concentration, allowing precise dosing in 100mcg increments using standard insulin syringe markings

Zenodo : 383396

FDA , U.S